Gentian is developing a turbidimetric immunoassay for quantification of calprotectin in plasma. A prototype assay was developed last year to prove the performance of such an assay, see publication, Nilsen et al. 2015, for performance characteristics.
We are planning clinical studies the next few years. If interested please contact us at firstname.lastname@example.org.